Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Lancet Infect Dis ; 7(3): 225-32, 2007 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-17317604

RESUMO

A 12-year-old girl with protracted tuberculous meningitis received standard chemotherapy and dexamethasone and had a progressive cerebrospinal fluid neutrophilia, raised protein and depressed glucose levels. Her temperature was raised for 5 months until a second course of dexamethasone was given. At week 15, multiple tuberculomas and hydrocephalus were detected followed by acute hydrocephalus (week 58), which required a ventricular-peritoneal shunt. Tuberculomas resolved after a second course of dexamethasone but recurred 15 months later. Immunological investigations were normal including integrity of the type 1 cytokine pathway. From month 24, interferon-gamma was given subcutaneously (initially 50 microg/m(2)) and continued for 19 months. Within 2 weeks she responded clinically followed by a reduction in inflammatory signs on magnetic resonance imaging scan (but not in the tuberculomas). At month 44, when chemotherapy was stopped, the cerebrospinal fluid/serum albumin quotient was 57x10(-3) (normal <6.0x10(-3)), which supports continuing major impairment of the blood-brain barrier. Gene expression in peripheral blood mononuclear cells before and during treatment with interferon-gamma, assessed by gene array analysis, showed reduction in a number of cytokine and chemokine genes. The response to interferon-gamma might have been secondary to downregulation of certain cytokine and chemokine genes.


Assuntos
Antituberculosos/uso terapêutico , Interferon gama/uso terapêutico , Tuberculose Meníngea/tratamento farmacológico , Tuberculose Meníngea/fisiopatologia , Anti-Inflamatórios/uso terapêutico , Antituberculosos/administração & dosagem , Líquido Cefalorraquidiano/química , Líquido Cefalorraquidiano/citologia , Quimiocinas/biossíntese , Quimiocinas/genética , Criança , Dexametasona/uso terapêutico , Feminino , Febre , Expressão Gênica , Glucose/líquido cefalorraquidiano , Humanos , Hidrocefalia/cirurgia , Interferon gama/administração & dosagem , Leucócitos Mononucleares/imunologia , Neutropenia , Tuberculoma , Tuberculose Meníngea/complicações
4.
Acta Paediatr ; 95(2): 182-8, 2006 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-16449024

RESUMO

BACKGROUND: Management of lymphadenopathy caused by nontuberculous mycobacteria (NTM) is primarily surgical. Where this cannot achieve sufficient clearance of infected nodes, chemotherapy is often given. AIM: This study compared results of surgery alone with surgery followed by chemotherapy in instances where there was incomplete surgical removal of diseased tissue. METHODS: Chemotherapy comprised azithromycin 10 mg/kg and rifabutin 6 mg/kg both given once daily for 6 mo. Ninety-eight children with NTM infection were seen in the period 1990-2004. Sixty-eight cases with adenopathy where "time to healing" (discharge stopped and inflammation settled) was known were available to compare response to treatment. RESULTS: The median (range) "time to healing" in weeks for 43 patients who had surgery alone was: incision and drainage (I&D)/curettage 6 (1-72) (n = 10); excision 3 (1-28) (n = 22); and from the last operation of multiple (repeat) surgery 3 (1-40) (n = 11). For 25 patients who required chemotherapy in addition to surgery, the median (range) "time to healing" in weeks was I&D/curettage 10 (1-40) (n = 17), excision 14 (8-20) (n = 2) and multiple surgery 29 (2-88) (n = 6). CONCLUSION: In children with adenitis due to NTM, where surgical resection is followed by continued discharge and inflammation, chemotherapy should be considered before further surgery is undertaken.


Assuntos
Linfadenite , Mycobacterium/isolamento & purificação , Cuidados Pós-Operatórios , Antibacterianos/uso terapêutico , Azitromicina/uso terapêutico , Criança , Pré-Escolar , Terapia Combinada , Extremidades , Face , Feminino , Humanos , Joelho , Linfadenite/tratamento farmacológico , Linfadenite/microbiologia , Linfadenite/cirurgia , Masculino , Pescoço , Glândula Parótida , Rifabutina/uso terapêutico , Fatores de Tempo , Cicatrização
5.
Pediatr Infect Dis J ; 22(2): 193-5, 2003 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-12613456

RESUMO

The value of HIV-1 IgA antibodies for early diagnosis of HIV infection in infants in serum, saliva and urine was investigated at Mulago Hospital, Kampala. Sensitivity and specificity in serum of HIV-infected infants at different ages were: 0 to 1 months, 88 and 95%; 1 to 3 months, 88 and 97%; 4 to 6 months, 80 and 96%. They decreased between 67 and 77% and 80 to 91%, respectively, in older age groups. Sensitivity for saliva was lower (53 to 79%) and urine only 37 to 62%, although specificity was reasonably high (>85%). The high proportion of infants with raised HIV IgA in the first months of life (88%) may represent prenatal infection. Sensitivity of serum and especially salivary and urinary HIV IgA is too low to be of practical value for early diagnosis of HIV infection in infants.


Assuntos
Anticorpos Anti-Idiotípicos/análise , Anticorpos Anti-HIV/imunologia , Infecções por HIV/imunologia , Imunoglobulina A/imunologia , Transmissão Vertical de Doenças Infecciosas , Complicações Infecciosas na Gravidez/diagnóstico , Adulto , Estudos de Coortes , Países em Desenvolvimento , Ensaio de Imunoadsorção Enzimática , Feminino , Anticorpos Anti-HIV/análise , Infecções por HIV/diagnóstico , Infecções por HIV/transmissão , HIV-1/imunologia , Humanos , Imunoglobulina A/análise , Imunoglobulina G/análise , Imunoglobulina G/imunologia , Incidência , Recém-Nascido , Masculino , Reação em Cadeia da Polimerase , Gravidez , Fatores de Risco , Saliva/virologia , Sensibilidade e Especificidade , Uganda/epidemiologia , Urinálise , Urina/virologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA